Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thomas P Matthews, Alan M Jones & Ian Collins. (2013) Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies. Expert Opinion on Drug Discovery 8:6, pages 621-640.
Read now
Read now
Edwardine Labay, Elena V Efimova, Benjamin K Quarshie, Daniel W Golden, Ralph R Weichselbaum & Stephen J Kron. (2011) Ionizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence. International Journal of High Throughput Screening 2, pages 1-13.
Read now
Read now
Heather L. Ball, Mark R. Ehrhardt, Daniel A. Mordes, Gloria G. Glick, Walter J. Chazin & David Cortez. (2007) Function of a Conserved Checkpoint Recruitment Domain in ATRIP Proteins. Molecular and Cellular Biology 27:9, pages 3367-3377.
Read now
Read now
Andrew S Chi & Patrick Y Wen. (2007) Inhibiting kinases in malignant gliomas. Expert Opinion on Therapeutic Targets 11:4, pages 473-496.
Read now
Read now
Patrick Y Wen, Santosh Kesari & Jan Drappatz. (2006) Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment. Expert Review of Anticancer Therapy 6:5, pages 733-754.
Read now
Read now
Articles from other publishers (43)
Ebrahim H. Maleki, Ahmad Reza Bahrami & Maryam M. Matin. (2024) Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance. Genes & Diseases 11:1, pages 189-204.
Crossref
Crossref
G. Michael Blackburn. 2022. Nucleic Acids in Chemistry and Biology. Nucleic Acids in Chemistry and Biology
421
476
.
Srimanta Patra, Biswajita Pradhan, Rabindra Nayak, Chhandashree Behera, Surajit Das, Samir Kumar Patra, Thomas Efferth, Mrutyunjay Jena & Sujit Kumar Bhutia. (2021) Dietary polyphenols in chemoprevention and synergistic effect in cancer: Clinical evidences and molecular mechanisms of action. Phytomedicine 90, pages 153554.
Crossref
Crossref
Srimanta Patra, Biswajita Pradhan, Rabindra Nayak, Chhandashree Behera, Krishna Chandra Panda, Surajit Das, Mrutyunjay Jena & Sujit Kumar Bhutia. (2021) Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: Current evidences and future perspectives. Phytotherapy Research 35:8, pages 4194-4214.
Crossref
Crossref
Srimanta Patra, Rabindra Nayak, Suryamani Patro, Biswajita Pradhan, Brundaban Sahu, Chhandashree Behera, Sujit Kumar Bhutia & Mrutyunjay Jena. (2021) Chemical diversity of dietary phytochemicals and their mode of chemoprevention. Biotechnology Reports 30, pages e00633.
Crossref
Crossref
Raelene Endersby, Jacqueline WhitehouseAllison PribnowMani Kuchibhotla, Hilary Hii, Brooke Carline, Suresh GandeJennifer Stripay, Mathew AncliffeMeegan Howlett, Tobias SchoepCourtney GeorgeClara AndradasPatrick DyerMarjolein Schluck, Brett PattersonSilvia K. Tacheva-GigorovaMatthew N. Cooper, Giles Robinson, Clinton Stewart, Stefan M. PfisterMarcel KoolTill Milde, Amar Gajjar, Terrance Johns, Robert J. Wechsler-Reya, Martine F. Roussel & Nicholas G. Gottardo. (2021) Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma. Science Translational Medicine 13:577.
Crossref
Crossref
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Pralay Das & Rituraj Purohit. (2021) Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants. Genomics 113:1, pages 707-715.
Crossref
Crossref
Elisa Feller Gonçalves da Silva, Kelly Goulart Lima, Gabriele Catyana Krause, Gabriela Viegas Haute, Leonardo Pedrazza, Anderson Velasque Catarina, Rodrigo Benedetti Gassen, Bruno de Souza Basso, Henrique Bregolin Dias, Carolina Luft, Maria Claudia Rosa Garcia, Bruna Pasqualotto Costa, Géssica Luana Antunes, Luiz Augusto Basso, Márcio Vinícius Fagundes Donadio, Pablo Machado & Jarbas Rodrigues de Oliveira. (2020) CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence. Investigational New Drugs 38:6, pages 1653-1663.
Crossref
Crossref
Khanh Nguyen, Bianca Nuß, Marina Mühlberger, Harald Unterweger, Ralf Friedrich, Christoph Alexiou & Christina Janko. (2020) Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation. Nanomaterials 10:8, pages 1577.
Crossref
Crossref
Heike J. Wobst, Korrie L. Mack, Dean G. Brown, Nicholas J. Brandon & James Shorter. (2020) The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future. Medicinal Research Reviews 40:4, pages 1352-1384.
Crossref
Crossref
Ge Yan & Thomas Efferth. 2020. Drug Repurposing in Cancer Therapy. Drug Repurposing in Cancer Therapy
295
310
.
Christopher C. Mills, EA. Kolb & Valerie B. Sampson. (2018) Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy. Cancer Research 78:2, pages 320-325.
Crossref
Crossref
Liliya Tyutyunyk-Massey, Syed U. Haqqani, Reshma Mandava, Kirubel Kentiba, Mallika Dammalapati, Nga Dao, Joshua Haueis, David Gewirtz & Joseph W. Landry. 2018.
1
39
.
Abhishek Basu, Arin Bhattacharjee, Prosenjit Ghosh, Amalesh Samanta & Sudin Bhattacharya. (2017) Sensitizing effects of an organovanadium compound during adjuvant therapy with cyclophosphamide in a murine tumor model. Biomedicine & Pharmacotherapy 93, pages 816-829.
Crossref
Crossref
Qing Zhou & Weihang Chai. (2016) Suppression of STN1 enhances the cytotoxicity of chemotherapeutic agents in cancer cells by elevating DNA damage. Oncology Letters 12:2, pages 800-808.
Crossref
Crossref
Marc A. Labroli, Michael P. Dwyer, Cory Poker, Kerry M. Keertikar, Randall Rossman & Timothy J. Guzi. (2016) A convergent preparation of the CHK1 inhibitor MK-8776 (SCH 900776). Tetrahedron Letters 57:24, pages 2601-2603.
Crossref
Crossref
Xiaodong Gao, Liping Han & Yujie Ren. (2016) In Silico Exploration of 1,7-Diazacarbazole Analogs as Checkpoint Kinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study, and Molecular Dynamics Simulations. Molecules 21:5, pages 591.
Crossref
Crossref
Chun He & James C.L. Chow. (2016) Gold nanoparticle DNA damage in radiotherapy: A Monte Carlo study. AIMS Bioengineering 3:3, pages 352-361.
Crossref
Crossref
Steven H. Lin & Ritsuko U. Komaki. 2014. Lung Cancer. Lung Cancer
390
405
.
Daniel S. Oh, Maggie C. U. Cheang, Cheng Fan & Charles M. Perou. (2014) Radiation-Induced Gene Signature Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. Radiation Research 181:2, pages 193.
Crossref
Crossref
Satoshi Ichikawa, Nana Tatebayashi & Akira Matsuda. (2013)
Synthesis of
C
-Glycosyl Pyrrolo[3,4-
c
]carbazole-1,3(2
H
,6
H
)-diones as a Scaffold for Check Point Kinase 1 Inhibitors
. The Journal of Organic Chemistry 78:23, pages 12065-12075.
Crossref
Crossref
S. Liu, S. O. Opiyo, K. Manthey, J. G. Glanzer, A. K. Ashley, C. Amerin, K. Troksa, M. Shrivastav, J. A. Nickoloff & G. G. Oakley. (2012) Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Research 40:21, pages 10780-10794.
Crossref
Crossref
Kai-Sheng Liu, Hui Liu, Jin-Huan Qi, Qiu-Yun Liu, Zhong Liu, Min Xia, Guo-Wen Xing, Shao-Xiang Wang & Yi-Fei Wang. (2012) SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells. Cancer Letters 318:2, pages 180-188.
Crossref
Crossref
Christopher Allen, Thomas B. Borak, Hirohiko Tsujii & Jac A. Nickoloff. (2011) Heavy charged particle radiobiology: Using enhanced biological effectiveness and improved beam focusing to advance cancer therapy. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 711:1-2, pages 150-157.
Crossref
Crossref
Marziyeh Lotfi, Sima Afsharnezhad, Hamid Reza Raziee, Kamran Ghaffarzadegan, Samaneh Sharif, Jamal Shamsara, Sara Lary & Javad Behravan. (2018) Immunohistochemical Assessment of MGMT Expression and p53 Mutation in Glioblastoma Multiforme. Tumori Journal 97:1, pages 104-108.
Crossref
Crossref
Michael P. Dwyer, Kamil Paruch, Marc Labroli, Carmen Alvarez, Kerry M. Keertikar, Cory Poker, Randall Rossman, Thierry O. Fischmann, Jose S. Duca, Vincent Madison, David Parry, Nicole Davis, Wolfgang Seghezzi, Derek Wiswell & Timothy J. Guzi. (2011) Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1. Bioorganic & Medicinal Chemistry Letters 21:1, pages 467-470.
Crossref
Crossref
Vibha Oza, Susan Ashwell, Patrick Brassil, Jason Breed, Chun Deng, Jay Ezhuthachan, Heather Haye, Candice Horn, James Janetka, Paul Lyne, Nicholas Newcombe, Ludo Otterbien, Martin Pass, Jon Read, Sian Roswell, Mei Su, Dorin Toader, Dingwei Yu, Yan Yu, Anna Valentine, Peter Webborn, Ann White, Sonya Zabludoff & Xiaolan Zheng. (2010) Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors—Hit to lead exploration. Bioorganic & Medicinal Chemistry Letters 20:17, pages 5133-5138.
Crossref
Crossref
Patrick Y. Wen, Eudocia Quant, Jan Drappatz, Rameen Beroukhim & Andrew D. Norden. (2010) Medical therapies for meningiomas. Journal of Neuro-Oncology 99:3, pages 365-378.
Crossref
Crossref
Andrew D. Norden & Patrick Y. Wen. 2010. Meningiomas. Meningiomas
667
679
.
Vicente Notario, Silvia Mateo-Lozano, Joaquín Villar & Oscar M. Tirado. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
2859
2871
.
Yongjian Zhu, Jue Hu, Yiduo Hu & Weiguo Liu. (2009) Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance. Cancer Treatment Reviews 35:7, pages 590-596.
Crossref
Crossref
Paul Okunieff, Lisa A. Kachnic, Louis S. Constine, Clifton D. Fuller, Laurie E. Gaspar, Daniel F. Hayes, Jean Hooks, Clifton Ling, Frank L. MeyskensJr.Jr., Philip A. Philip, David Raben, Stephen R. Smalley, Gregory P. Swanson, Beverly A. Teicher, Charles R. ThomasJr.Jr., Bhadrasain Vikram, Michael J. Zelefsky & Laurence H. Baker. (2009) Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008. Clinical Cancer Research 15:18, pages 5663-5670.
Crossref
Crossref
Thomas P. Matthews, Suki KlairSamantha Burns, Kathy Boxall, Michael CherryMartin FisherIsaac M. Westwood, Michael I. Walton, Tatiana McHardy, Kwai-Ming J. Cheung, Rob Van Montfort, David WilliamsG. Wynne Aherne, Michelle D. Garrett, John ReaderIan Collins. (2009) Identification of Inhibitors of Checkpoint Kinase 1 through Template Screening. Journal of Medicinal Chemistry 52:15, pages 4810-4819.
Crossref
Crossref
P.K. Raveedran Nair, Steven J. Melnick, Stanislaw F. Wnuk, Magdalena Rapp, Enrique Escalon & Cheppail Ramachandran. (2009) Isolation and characterization of an anticancer catechol compound from Semecarpus anacardium. Journal of Ethnopharmacology 122:3, pages 450-456.
Crossref
Crossref
Alessandra Blasina, Jill Hallin, Enhong Chen, Maria Elena Arango, Eugenia Kraynov, James Register, Stephan Grant, Sacha Ninkovic, Ping Chen, Tim Nichols, Patrick O'Connor & Kenna Anderes. (2008) Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. Molecular Cancer Therapeutics 7:8, pages 2394-2404.
Crossref
Crossref
James W. Janetka, Lynsie Almeida, Susan Ashwell, Patrick J. Brassil, Kevin Daly, Chun Deng, Thomas Gero, Roberta E. Glynn, Candice L. Horn, Stephanos Ioannidis, Paul Lyne, Nicholas J. Newcombe, Vibha B. Oza, Martin Pass, Stephanie K. Springer, Mei Su, Dorin Toader, Melissa M. Vasbinder, Dingwei Yu, Yan Yu & Sonya D. Zabludoff. (2008) Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 18:14, pages 4242-4248.
Crossref
Crossref
Andrew D. Norden, Jan Drappatz & Patrick Y. Wen. (2007) Targeted drug therapy for meningiomas. Neurosurgical FOCUS 23:4, pages E12.
Crossref
Crossref
Andrew D. Norden, Jan Drappatz & Patrick Y. Wen. (2007) Targeted drug therapy for meningiomas. Neurosurgical Focus 23:4, pages E12.
Crossref
Crossref
Giovanna Damia & Maurizio D’Incalci. (2007) Targeting DNA repair as a promising approach in cancer therapy. European Journal of Cancer 43:12, pages 1791-1801.
Crossref
Crossref
Yunsong Tong, Akiyo Claiborne, Kent D. Stewart, Chang Park, Peter Kovar, Zehan Chen, Robert B. Credo, Wen-Zhen Gu, Stephen L. GwaltneyIIII, Russell A. Judge, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham, Thomas J. Sowin & Nan-horng Lin. (2007) Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors. Bioorganic & Medicinal Chemistry 15:7, pages 2759-2767.
Crossref
Crossref
D. N. Kalyuzhnyi, V. V. TatarskiiJr.Jr., F. S. Bondarev, I. L. Plikhtyak, T. D. Miniker, S. Ya. Mel’nik, A. A. Shtil’ & O. F. Borisova. (2006) Interaction with DNA as a cytotoxicity factor of a novel glycoside derivative of indolocarbazole. Doklady Biochemistry and Biophysics 411:1, pages 365-368.
Crossref
Crossref
Martin Egli, Andy Flavell, Anna Marie Pyle, W David Wilson, S Ihtshamul Haq, Ben Luisi, Julie Fisher, Charlie Laughton, Stephanie Allen, Joachim Engels, Jane A Grasby & Stephen Neidle. 2006. Nucleic Acids in Chemistry and Biology. Nucleic Acids in Chemistry and Biology
295
340
.
Jian Ding, Ze-Hong Miao, Ling-Hua Meng & Mei-Yu Geng. (2006) Emerging cancer therapeutic opportunities target DNA-repair systems. Trends in Pharmacological Sciences 27:6, pages 338-344.
Crossref
Crossref